ArticleBMC plant biology2026
Untargeted metabolomics suggests a trade-off between phenolamides and flavonoids in the pollen of Petunia hybrida with contrasting flower colours.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Allergic Respiratory Diseases in the Climate Change Context: Aerobiological Tools and Projections as Preventive Actions for Pollen-Induced Allergies.Medical sciences (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPollen is vital for reproduction of flowering plants. Several nutritional and biological benefits for humans and pollinators are described and related to its richness and diversity of metabolites. However, the chemical composition of pollen from several horticulturally significant plant species, such as those in the genus Petunia, has not been thoroughly characterised. Here, we present the first comprehensive description of the chemical profile of two distinct P. hybrida lines: V26 (violet flowers) and W115 (white flowers) using untargeted metabolomics. Our workflow started from pollen sampling and isolation, followed by a 3-in-1 liquid phase extraction for wide-range metabolite recovery, and data acquisition by ultra-high-performance liquid chromatography coupled to high-resolution tandem mass spectrometry (UHPLC-HRMS/MS) using three chromatographic columns (C8, C18, and HILIC) with positive and negative ionisation. For data analysis, we implemented a user-friendly and reproducible data processing pipeline based on open-source computational tools.
resultsThe P. hybrida pollen is rich in glycosylated flavonoids, phenolamides, and lipids, which were detected mostly in non-polar phase extracts analysed by reversed-phase chromatography. Simple phenylpropanoids, fatty acids, amino acids, and terpenoids were annotated to a lesser extent. Statistical analyses integrated with molecular networking demonstrated a distinct metabolic dichotomy: phenolamide derivatives are predominantly present in the pollen of the V26 line, while flavonoids are accumulated in the pollen of W115. This finding suggests different regulation of the phenylpropanoid metabolism in pollen of P. hybrida lines with differing flower colours and sheds light on hypotheses of ecological roles of pollen secondary metabolites, for example, in plant-pollinator interactions.
conclusionsOur findings suggest a metabolic trade-off in the phenylpropanoid pathway in the two studied P. hybrida lines. These cultivar-specific chemical signatures may have significant implications for pollen viability and interactions with pollinators. Furthermore, our analytical and computational workflow serves as a robust template for the deep metabolic profiling of other under-characterised and complex natural matrices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.